Insider: Huizenga Theodore Alan SVP, Chief Accounting Officer - Ultragenyx Pharmaceutical Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 50,242 | 0 | 50,242 |
| Value | $1,397,732.44 | $0.00 | $1,397,732.44 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/18/2025 | DDS | 64 | Direct | COM | $29.17 | $1,866.88 | 50,242 |
| 09/05/2025 | DDS | 84 | Direct | COM | $31.39 | $2,636.76 | 50,306 |
| 03/03/2025 | DDS | 967 | Direct | COM | $42.10 | $40,710.70 | 50,265 |
| 09/03/2024 | DDS | 91 | Direct | COM | $56.19 | $5,113.29 | 41,551 |
| 03/01/2024 | DDS | 341 | Direct | COM | $53.76 | $18,332.16 | 41,380 |
| 09/07/2023 | DDS | 2,000 | Direct | COM | $41.00 | $82,000.00 | 23,777 |
| 09/07/2023 | DDS | 163 | Direct | COM | $38.34 | $6,249.42 | 23,614 |
| 09/01/2023 | DDS | 883 | Direct | COM | $37.04 | $32,706.32 | 23,864 |
| 09/01/2023 | DDS | 87 | Direct | COM | $38.23 | $3,326.01 | 23,777 |
| 03/01/2023 | DDS | 100 | Direct | COM | $45.65 | $4,565.00 | 23,048 |
| 02/28/2023 | DDS | 639 | Direct | COM | $43.40 | $27,732.60 | 15,558 |
| 12/21/2022 | DDS | 2,031 | Direct | COM | $43.96 | $89,282.76 | 16,197 |
| 04/16/2022 | DDS | 132 | Direct | COM | $84.55 | $11,160.60 | 16,914 |
| 03/01/2022 | DDS | 843 | Direct | COM | $66.62 | $56,160.66 | 13,229 |
| 10/14/2021 | DDS | 140 | Direct | COM | $81.14 | $11,359.60 | 14,072 |
| 05/06/2021 | DDS | 142 | Direct | COM | $113.67 | $16,141.14 | 15,031 |
| 03/08/2021 | DDS | 3,000 | Direct | COM | $120.69 | $362,070.00 | 13,544 |
| 03/01/2021 | DDS | 732 | Direct | COM | $138.17 | $101,140.44 | 16,544 |
| 01/07/2021 | DDS | 4,000 | Direct | COM | $140.65 | $562,600.00 | 15,716 |
| 10/14/2020 | DDS | 146 | Direct | COM | $87.98 | $12,845.08 | 16,436 |
| 07/08/2020 | DDS | 638 | Direct | COM | $91.00 | $58,058.00 | 16,582 |
| 07/08/2020 | DDS | 2,000 | Direct | COM | $91.00 | $182,000.00 | 16,582 |
| 07/01/2020 | DDS | 1,111 | Direct | COM | $81.00 | $89,991.00 | 17,220 |
| 07/01/2020 | DDS | 1,500 | Direct | COM | $81.00 | $121,500.00 | 17,220 |
| 05/26/2020 | DDS | 260 | Direct | COM | $74.93 | $19,481.80 | 18,331 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research